Human medicines European public assessment report (EPAR): Rayvow, lasmiditan, Date of authorisation: 17/08/2022, Revision: 6, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 6 February 2026 - 12:55

Human medicines European public assessment report (EPAR): Rayvow, lasmiditan, Date of authorisation: 17/08/2022, Revision: 6, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/rayvow

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters